U.S. Software Stock News

NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq (NDAQ) Pricing Look Justified After Strong Multi Year Share Gains?

If you are asking whether Nasdaq stock looks reasonably priced or stretched right now, you are in the right place for a clear, valuation focused look at the numbers. The share price closed at US$96.89 recently, with returns of 19.1% over 1 year, 67.0% over 3 years and 118.2% over 5 years. Shorter term moves of a 1.2% decline over 7 days and a 0.2% decline over 30 days show a more muted picture. Recent coverage has focused on Nasdaq's role in capital markets infrastructure and ongoing...
NYSE:CNH
NYSE:CNHMachinery

CNH Industrial’s R4 Robot Extends Automation Push Into Specialty Crop Services

CNH Industrial (NYSE:CNH) has introduced its R4 autonomous robot, aimed at addressing labor shortages in specialty crop farming. The launch focuses on automated solutions for tasks in high value crops where finding and retaining workers can be difficult. This move builds on CNH Industrial's broader push into automation and robotics within agriculture equipment. For you as an investor, the R4 robot sits at the intersection of machinery, software, and farm operations, an area that has been...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Is Tilray Brands' (TLRY) Italian Medical Push Quietly Redefining Its Global Cannabis Strategy?

Earlier in January 2026, Tilray Medical, a division of Tilray Brands, expanded its European medical cannabis operations by launching Tilray Medical Italia, rebranding the former FL Group and broadening an Italian Ministry of Health–authorized product portfolio in partnership with Molteni Farmaceutici. This move not only deepens Tilray’s presence in one of Europe’s most tightly regulated medical cannabis markets, it also advances its goal of building a unified global medical cannabis platform...
NasdaqGM:TVTX
NasdaqGM:TVTXBiotechs

Is Travere Therapeutics (TVTX) Offering Value After Recent Share Price Swings?

If you are wondering whether Travere Therapeutics at around US$31.09 is offering fair value or an opportunity, you are not alone. This article is built to help you size that up clearly. The stock has had a mixed run, with a 5.6% gain over the last 7 days but an 18.6% decline over 30 days, while still sitting on a 52.0% return over 1 year and 43.1% over 3 years, compared with a 2.1% decline over 5 years. Recent coverage of Travere Therapeutics has focused on its position in the...
NYSE:ANF
NYSE:ANFSpecialty Retail

A Look At Abercrombie & Fitch (ANF) Valuation After Its New NFL Super Bowl Fashion Partnership

Abercrombie & Fitch (ANF) is back in focus after being named the NFL's Official Fashion Partner for the upcoming Super Bowl, tying its stock story to high visibility events across sports and fashion. See our latest analysis for Abercrombie & Fitch. The Super Bowl tie up comes at a time when Abercrombie & Fitch’s share price of $97.63 sits below recent highs. A 90 day share price return of 34.57% contrasts with a 22.44% decline over 30 days and a three year total shareholder return of 224.68%,...
NYSE:LUV
NYSE:LUVAirlines

Is It Too Late To Consider Southwest Airlines (LUV) After Its Strong Share Price Run?

If you are wondering whether Southwest Airlines is still fairly priced after its recent run, you are not alone. This article focuses squarely on what the current share price might be implying. The stock recently closed at US$47.52, with returns of 13.3% over 7 days, 15.0% over 30 days, 15.1% year to date, 58.1% over 1 year and 39.8% over 3 years, while the 5 year return stands at 2.0%. Recent headlines around Southwest Airlines have focused on its operational recovery and route capacity...
NYSE:GENI
NYSE:GENIHospitality

Reassessing Genius Sports (GENI) After Recent Share Price Weakness And DCF Upside Potential

If you are wondering whether Genius Sports is offering fair value at its current price, you are not alone, as the stock has been attracting attention from investors who want to know what they are really paying for its growth story. The shares last closed at US$8.70, with returns of a 10% decline over 7 days, a 21.1% decline over 30 days, a 19.3% decline year to date and a 1.5% decline over 1 year, while the 3 year return sits at 59.3% and the 5 year return at a 58.1% decline. Recent news...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp (EWBC) Valuation After Earnings Beat And 33% Dividend Increase

East West Bancorp (EWBC) just reported stronger than expected fourth quarter results and announced a 33% increase in its quarterly dividend to $0.80 per share, a combination that sharpened the market’s focus on the stock. See our latest analysis for East West Bancorp. The latest set of results and the higher dividend come after a strong run for the stock, with a 90 day share price return of 12.64% and a 1 year total shareholder return of 13.93%. The 5 year total shareholder return of 100.36%...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Is Cirrus Logic (CRUS) Pricing Make Sense After Strong Multi‑Year Share Price Gains

If you are wondering whether Cirrus Logic shares still offer value at current levels, this article walks through what the numbers are really saying about the stock. The share price last closed at US$130.34, with returns of 2.4% over 7 days, 10.0% over 30 days, 8.9% year to date, 29.8% over 1 year and 52.7% over 5 years, which may have caught the attention of investors who follow price trends closely. Recent coverage around Cirrus Logic has focused on its role in the semiconductor space and...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Earnings Growth Of 16.3% Reinforces Premium Valuation Narrative

Latest FY 2025 earnings snapshot Mastercard (MA) has wrapped up FY 2025 with Q4 revenue of US$8.8b and basic EPS of US$4.53, setting the tone for a year where trailing 12 month revenue reached US$32.8b and EPS came in at US$16.54, alongside trailing earnings growth of 16.3% year over year. Over the last six reported quarters, the company has seen quarterly revenue move from US$7.5b in Q4 2024 to US$8.8b in Q4 2025. Basic EPS over that same span has ranged from US$3.54 in Q3 2024 to US$4.53 in...
NYSE:HTH
NYSE:HTHBanks

Hilltop Holdings Ups Dividend And Buybacks As Earnings Strengthen

Hilltop Holdings (NYSE:HTH) raised its quarterly dividend by 11% following its latest full year results. The company also authorized a new US$125 million share repurchase program. These capital return actions arrive after a year of improved profitability and strong financial performance. For you as an investor, this move puts fresh attention on Hilltop Holdings, a financial services company active in banking and other related lines of business. The higher dividend and new buyback plan come...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ Board Review Puts Full Sale And Business Model In Focus

LKQ's board has started a formal review of the business, including the option of selling the entire company. The process is aimed at evaluating potential changes to ownership and operations that could affect shareholders and creditors. This review follows a period of mixed share performance and comes with the stock last closing at $32.85. For investors in NasdaqGS:LKQ, this announcement comes after a stretch of uneven returns. The stock is up 8.8% over the past month and 9.4% year to date,...
NYSE:IOT
NYSE:IOTSoftware

Is It Time To Reassess Samsara (IOT) After Recent Share Price Slide?

If you are wondering whether Samsara's current share price really reflects its long term potential, you are asking the same question this article set out to tackle. The stock has seen a 12.6% decline over the last week, a 20.9% decline over the last month, a 17.3% decline year to date and a 45.5% decline over the last year, although the three year return sits at 90.7%. Recent coverage has focused on how Samsara fits into broader themes in connected operations and software as a service, with...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Is Ultragenyx Pharmaceutical (RARE) Pricing Reflect Its Rare Disease Pipeline Progress And Share Slump

If you are wondering whether Ultragenyx Pharmaceutical at around US$24 per share offers value or just more volatility, you are not alone. This article focuses squarely on what the current price might be implying. The stock has seen mixed returns, with a 4.7% gain over the last 30 days and a 2.0% return year to date, set against a 44.1% decline over 1 year, 47.4% over 3 years and 85.2% over 5 years. Recent news coverage around Ultragenyx has revolved around its position in the rare disease...
NYSE:CMC
NYSE:CMCMetals and Mining

Is It Too Late To Reassess Commercial Metals (CMC) After Its Recent 60% One Year Rally

If you are wondering whether Commercial Metals is still attractively priced after a strong run, this article walks through what the numbers currently say about its value. The stock recently closed at US$76.87, with returns of 11.1% over the last 30 days, 7.1% year to date, 60.6% over 1 year and 41.4% over 3 years. Over the last 7 days there has been a 0.8% decline that may have caught your eye. Recent news coverage has focused on Commercial Metals as an established name in steel and metal...
NYSE:NCLH
NYSE:NCLHHospitality

Is Norwegian Cruise Line Holdings (NCLH) Pricing Reflect Recent Share Weakness Or Long Term Potential

Wondering whether Norwegian Cruise Line Holdings at around US$21.96 is a potential bargain or a value trap? This article walks through what the current price might be telling you. The stock has had a mixed run, with a 4.9% gain over the last 7 days, a 1.6% decline over 30 days, a 3.6% decline year to date, a 22.5% decline over 1 year, a 32.5% return over 3 years, and an 11.2% decline over 5 years. Recent attention around the cruise industry, including ongoing discussions on travel demand,...
NYSE:RXO
NYSE:RXOTransportation

Is RXO (RXO) Offering Value After Recent Share Price Swings And DCF Estimate Gap

If you are looking at RXO and wondering whether the current share price gives you good value, this article will walk through what the numbers are really saying about the stock. RXO's share price recently closed at US$14.58, with a 7 day return of 6.2% decline, a 30 day return of 15.3%, a year to date return of 13.6% and a 1 year return of 43.2% decline. This suggests the market's view on the company has shifted more than once over different time frames. Recent coverage around RXO has focused...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Blackbaud’s AI Philanthropy Links Workforce Impact With Undervalued Stock Story

Blackbaud (NasdaqGS:BLKB) announced a multi-year, six-figure major gift to Generation: You Employed. The commitment is focused on global workforce development through AI-driven training programs. The partnership is aimed at supporting economic mobility for underserved communities worldwide. The initiative aligns Blackbaud's philanthropy with its focus on responsible AI and social impact software. For investors watching NasdaqGS:BLKB, this move ties directly into the company’s role as a...
NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue (KVUE) Valuation Check After Mixed Recent Returns And Fair Value Debate

Kenvue stock reaction and recent performance Kenvue (KVUE) has been on investors’ radar after its recent trading swings, with the stock closing at $17.40 and showing mixed returns over the past week, month and past 3 months. Over the past week the share price reflected a 2.2% decline, while the month return sits near 0.9%. Looking at the past 3 months, Kenvue shows a 21.1% total return against a 14.9% decline over the past year. See our latest analysis for Kenvue. For Kenvue, the recent 21.1%...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast (CMCSA) Margin Strength Reinforces Bullish Narratives Despite Flat Revenue Trend

Comcast (CMCSA) has wrapped up FY 2025 with fourth quarter revenue of US$32.3b and basic EPS of US$0.60, alongside trailing twelve month revenue of US$123.7b and EPS of US$5.39. Over the last six reported quarters, revenue has ranged from US$29.9b to US$32.3b, while quarterly EPS has moved between US$0.60 and US$2.99. This gives investors a clear view of how earnings per share translate off a large and relatively steady top line base. With a trailing net margin of 16.2% against 13.1% a year...
NYSE:MTX
NYSE:MTXChemicals

Minerals Technologies (MTX) Trailing Loss Challenges Bullish Narrative After Q4 Profit

Minerals Technologies (MTX) has wrapped up FY 2025 with fourth quarter revenue of US$519.5 million and EPS of US$1.19, set against a 12‑month backdrop where trailing revenue sat at about US$2.1 billion and EPS was slightly negative at US$0.59. Over recent quarters the company has seen quarterly revenue move from US$518.1 million in Q4 2024 to US$528.9 million in Q2 2025 and US$532.4 million in Q3 2025 before landing at US$519.5 million in Q4 2025. Over the same period, EPS shifted from...
NasdaqGS:BPOP
NasdaqGS:BPOPBanks

Is It Too Late To Consider Popular (BPOP) After Strong Multi Year Share Price Gains

If you are wondering whether Popular's share price still reflects good value or if most of the opportunity is already priced in, this article walks through the key signals you can use to form your own view. Popular's shares last closed at US$133.53, with returns of 9.5% over the past 7 days, 7.2% over 30 days, 6.0% year to date, 33.3% over 1 year, 106.6% over 3 years, and 149.1% over 5 years. These figures raise fair questions about what is now built into expectations and perceived...